International Immunopharmacology
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
International Immunopharmacology
INT IMMUNOPHARMACOL
ISSN / eISSN
1567-5769 / 1878-1705
Aims and Scope
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
The subject material appropriate for submission includes:
• Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders.
• Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state.
• Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses.
• Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action.
• Agents that activate genes or modify transcription and translation within the immune response.
• Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active.
• Production, function and regulation of cytokines and their receptors.
• Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.
Subject Area
IMMUNOLOGY
PHARMACOLOGY & PHARMACY
CiteScore
8.70
View Trend
CiteScore Ranking
| Category | Quartile | Rank |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics - Pharmacology | Q1 | #50/301 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology and Allergy | Q2 | #56/211 |
| Pharmacology, Toxicology and Pharmaceutics - Immunology | Q2 | #61/217 |
Web of Science Core Collection
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| Category (Journal Citation Reports 2023) | Quartile |
|---|---|
| IMMUNOLOGY - SCIE | Q2 |
| PHARMACOLOGY & PHARMACY - SCIE | Q1 |
H-index
98
Country/Area of Publication
NETHERLANDS
Publisher
Elsevier
Publication Frequency
Monthly
Year Publication Started
2001
Annual Article Volume
1030
Open Access
NO
Contact
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
Verified Reviews
January 10th: Under review
March 11th: First review comments received
April 6th: Submitted revised draft
April 18th: Review process complete, currently unsure of feedback
First reviewer provided specific feedback on the article's structure and writing logic, acknowledging its innovative research. Made targeted revisions accordingly. Second reviewer did not provide specific issues, only stating that the language was poor and the design was bad, resulting in rejection. Fortunately, the editor noticed the lack of specific feedback from the second reviewer and did not heavily consider their opinion. The entire manuscript was revised and marked in red. The first reviewer likely returned their comments for revisions the following day, while the second reviewer took over a week, and it is unknown whether they agreed or disagreed.
Hoping for an acceptance and publication soon, as it has been only a few days. Will provide updates if there are any news.
Submitted on December 5th.
Received major revision on January 6th, given two months of time (two reviewers, one more negative and one positive, each provided several questions for modification, the reviewers' comments were acceptable; the editor's comment was that the language needs polishing). Due to being busy in January, I didn't have time to do the major revision and only started it formally in early February after the Lunar New Year. During this period, I sought help from a company for language polishing.
Received the revised version on February 22nd.
Minor revision on March 8th, as there was unclear indexing on one image.
Second minor revision on March 12th, moving the image to the supplementary materials.
Accepted on March 14th.
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search